![Dr Carl Counsell Dr Carl Counsell](/img/200x200/staffpages/uploads/mmd528/Carl_Counsell_ID.jpg)
MRCP, MSc, MD
Reader (Clinical)
- About
-
- Email Address
- carl.counsell@abdn.ac.uk
- Office Address
Room 1:009, Polwarth Building Division of Applied Health Sciences University of Aberdeen Foresterhill Aberdeen AB25 2ZD
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Carl is a clinical reader and honorary consultant in neurology. He graduated in medicine from Cambridge University in 1988, did his early postgraduate medical training in London, Newcastle and Falkirk and then trained in neurology, stroke and epidemiology in Edinburgh. He spent a year in Melbourne where he specialised in movement disorders before taking up his present post in 2001. He is married to Gay, a GP, and has one daughter, Helena. A committed Christian, he would like to have more time to serve in his church and develop his interests in Fairtrade and conservation.
Latest Publications
Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study
Journal of Neurology, vol. 271, pp. 2929-2937Contributions to Journals: ArticlesTotal Patient Delay: A comparison of patient and clinician/health system delays in the diagnosis of progressive supranuclear palsy and corticobasal syndrome
Movement Disorders Clinical Practice, vol. 11, no. 5, pp. 478-487Contributions to Journals: ArticlesIncidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism
Parkinsonism & Related Disorders, vol. 118Contributions to Journals: ArticlesProgressive multifocal leukoencephalopathy associated with carbamazepine -: induced immune dysfunction and recovery after carbamazepine cessation
BMJ Case Reports, vol. 16, no. 7, e255119Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bcr-2023-255119
- [ONLINE] View publication in Scopus
The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
Journal of Neurology, vol. 270, pp. 3464-3474Contributions to Journals: Articles
- Research
-
Research Overview
Carl is a consultant neurologist with subspecialty interest in movement disorders. His main research interests are in evidence-based medicine and broader aspects of clinical epidemiology such as incidence and prognostic studies, particularly in relation to Parkinson's disease, other movement disorders and stroke. His team have established several cohorts of parkinsonian patients for long-term follow-up and support a number of non-industry sponsored clinical trials and Cochrane reviews, whilst also trying to promote multidisciplinary neurology research in Aberdeen.
Research Areas
Accepting PhDs
I am currently accepting PhDs in Nutrition and Health.
Please get in touch if you would like to discuss your research ideas further.
Nutrition and Health
Accepting PhDsResearch Specialisms
- Clinical Medicine
Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.
Current Research
The PINE study: a population-based incidence cohort of people with Parkinson's disease and other parkinsonian disorders, along with their carers and controls who are being followed up lifelong to establish long-term prognosis.
The Parkinson's Incidence Cohorts Collaboration: an individual patient data meta-analysis of all population- based incidence cohorts of Parkinson's disease to assess prognosis and allow prognostic modelling.
The Scottish PSP/CBD prevalence cohort: a cohort of people with two related Parkinson's plus disorders, Progressive Supranuclear Palsy and Corticobasal Degeneration as well as Parkinson's disease controls, to assess diagnostic and care pathways and prognosis.
Past Research
Cochrane systematic reviews of randomised trials in stroke care
Prognostic modelling in acute stroke
Incidence of Parkinson's disease and other parkinsonian disorders in North-East Scotland
Prevalence of multiple sclerosis in North-East Scotland and northern isles
Randomised trial of physiotherapy for cervical dystonia
Knowledge Exchange
Member of Parkinson's Excellence Network
Collaborations
Cochrane Collaboration Stroke Review Group, Professors Charles Warlow and Peter Sandercock, University of Edinburgh, UK, 1993-98.
Scottish Audit of Intracranial Vascular Malformations, Professor Rustam Al-Shahi Salman, University of Edinburgh, UK, 2002-2014.
PDMED trial, Professor Carl Clarke, University of Birmingham, UK, 2004-2020.
Clinical trial methods in neurodegenerative diseases, Professor John Zajicek, University of Plymouth, UK, 2009-2014.
PDCOMM trial, Professor Sackley, University of Nottingham, UK, 2016-2023.
NICE technology appraisals for multiple sclerosis, Universities of Warwick and Exeter, UK, 2016-2022
Parkinson's Incidence Cohorts Collaboration, Professor Tysnes, Dr Guido Alves, Professor Lars Forsgren, Dr Caroline Williams-Gray, Dr Alison Yarnall, Universities of Stavanger (Norway), Umea (Sweden), Cambridge (UK) and Newcastle (UK), 2018 ongoing
PD Connect exercise trial, Julie Jones, Robert Gordon University, Aberdeen, UK, 2019-2022
Supervision
Dr Kate Taylor (MD), 2002-06, Incidence and prognosis of parkinsonism in north-east Scotland: a pilot study.
Clare Harris (MSc), 2006-08, PINE participants attitudes to brain donation.
Dr Robert Caslake (PhD), 2006-11, Incidence and short-term porgnosis of Parkinson's disease andother parkinsonian disorders in north-east Scotland.
Dr Elizabeth Visser (MD), 2009-13, Prevalence of multiple sclerosis in northern Scotland.
Dr David McGhee (PhD), 2009-13, Improving clinical trial design in neurodegenerative diseases.
Dr Angus Macleod (PhD), 2012-15, Predicting mortality and dependency in Parkinson's disease.
Dr Diane Swallow (PhD), 2016-21, Assessing diagnostic pathways in progressive supranuclear palsy and corticobasal degeneration.
Funding and Grants
Research funding has been obtained from:
Parkinson’s UK, Scottish Chief Scientist Office, BMA Doris Hillier award, RS Macdonald Trust, BUPA Foundation, NHS Grampian endowments, Dystonia Society, National Institute for Health Research.
- Teaching
-
Teaching Responsibilities
Lectures and clinical teaching of neurology for medical and dental students.
Supervising medical student elective and MSc projects
Non-course Teaching Responsibilities
Regent to medical students
- Publications
-
Page 9 of 20 Results 81 to 90 of 191
Parkinsonism Incidence in Northeast Scotland (The Pine Study): The Incidence of Parkinson's Disease and Parkinsonism
Age and Ageing, vol. 41, pp. 68Contributions to Journals: AbstractsThe Incidence of Progressive Supranuclear Palsy, Multiple System Atrophy and Vascular Parkinsonism in Northeast Scotland (The Pine Study)
Age and Ageing, vol. 41, pp. 69Contributions to Journals: AbstractsSystematic review of biomarkers for disease progression in Parkinson's disease
Annual Meeting of the Association of British Neurologists, pp. e1Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1136/jnnp-2011-301993.157
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease
Journal of Neurology, vol. 259, no. 3, pp. 462-468Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00415-011-6202-y
The documentation of lumbar puncture for acute headache presentations: a re-audit
International Journal of Clinical Practice, vol. 65, no. 11, pp. 1201-1202Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1111/j.1742-1241.2011.02764.x
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS - PARKINSON PLUS SCALE
PloS ONE, vol. 6, no. 8, e22293Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1371/journal.pone.0022293
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3525/1/Disease_severity.pdf
The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal
Applied Health Economics and Health Policy, vol. 9, no. 4, pp. 243-258Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2165/11590160-000000000-00000
Seizure risk from cavernous or arteriovenous malformations: prospective population-based study
Neurology, vol. 76, no. 18, pp. 1548-1554Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1212/WNL.0b013e3182190f37
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet, vol. 377, no. 9766, pp. 641-649Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0140-6736(10)62345-8
Orphan drugs: Regulation is flawed
BMJ (Clinical research ed.), vol. 341, c7016Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1136/bmj.c7016